Selective inducible nitric oxide synthase suppression by new bracteanolides from Murdannia bracteata

Guei Jane Wang, Shih Ming Chen, Wei Chou Chen, Yu Min Chang, Zong-Huei Li

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Murdannia bracteata has been used as a Taiwanese folk medicine for its anti-inflammatory properties. However, neither its active ingredients nor its anti-inflammatory actions are well defined. Nitric oxide (NO), overproduced by activated macrophages via inducible NO synthase (iNOS), is suggested to be a significant pathogenic factor in various inflammatory tissue injuries. In order to elucidate the anti-inflammatory actions of M. bracteata, the present study was designed to isolate its active constituents and examine its effects on iNOS in lipopolysaccharide (LPS)-activated macrophages. Two new hydroxybutenolides, bracteanolide A (1) and B (2), together with (+)-(R)-p-hydroxyphenyllactic acid (3) and isovitexin (4), were isolated and identified from M. bracteata by the NO production assay. All of the compounds inhibited NO production except 3. Their rank order of potency was 1 > 2 > 4. Among these, 1 significantly inhibited NO production, which is associated with its suppression on iNOS induction in a concentration-dependent manner, with an IC50 of 33.27 ± 0.86 μM. Nevertheless, isometric tension recordings in isolated endothelium-intact rat aorta revealed that 1-4 did not affect acetylcholine-induced endothelial NO-dependent relaxation, an index of endothelial NOS (eNOS) activity. The selective inhibition on iNOS provides a possible explanation for the anti-inflammatory use of M. bracteata.

Original languageEnglish
Pages (from-to)221-227
Number of pages7
JournalJournal of Ethnopharmacology
Volume112
Issue number2
DOIs
Publication statusPublished - Jun 13 2007

Fingerprint

Nitric Oxide Synthase Type II
Nitric Oxide
Anti-Inflammatory Agents
Nitric Oxide Synthase
Macrophages
Traditional Medicine
Inhibitory Concentration 50
Acetylcholine
Endothelium
Lipopolysaccharides
Aorta
Acids
Wounds and Injuries

Keywords

  • Bracteanolide A
  • Bracteanolide B
  • Commelinaceae
  • Inducible nitric oxide synthase
  • Murdannia bracteata
  • RAW 264.7 cells

ASJC Scopus subject areas

  • Pharmacology

Cite this

Selective inducible nitric oxide synthase suppression by new bracteanolides from Murdannia bracteata. / Wang, Guei Jane; Chen, Shih Ming; Chen, Wei Chou; Chang, Yu Min; Li, Zong-Huei.

In: Journal of Ethnopharmacology, Vol. 112, No. 2, 13.06.2007, p. 221-227.

Research output: Contribution to journalArticle

Wang, Guei Jane ; Chen, Shih Ming ; Chen, Wei Chou ; Chang, Yu Min ; Li, Zong-Huei. / Selective inducible nitric oxide synthase suppression by new bracteanolides from Murdannia bracteata. In: Journal of Ethnopharmacology. 2007 ; Vol. 112, No. 2. pp. 221-227.
@article{e3d876896d464b20a8f31c02c9a0655d,
title = "Selective inducible nitric oxide synthase suppression by new bracteanolides from Murdannia bracteata",
abstract = "Murdannia bracteata has been used as a Taiwanese folk medicine for its anti-inflammatory properties. However, neither its active ingredients nor its anti-inflammatory actions are well defined. Nitric oxide (NO), overproduced by activated macrophages via inducible NO synthase (iNOS), is suggested to be a significant pathogenic factor in various inflammatory tissue injuries. In order to elucidate the anti-inflammatory actions of M. bracteata, the present study was designed to isolate its active constituents and examine its effects on iNOS in lipopolysaccharide (LPS)-activated macrophages. Two new hydroxybutenolides, bracteanolide A (1) and B (2), together with (+)-(R)-p-hydroxyphenyllactic acid (3) and isovitexin (4), were isolated and identified from M. bracteata by the NO production assay. All of the compounds inhibited NO production except 3. Their rank order of potency was 1 > 2 > 4. Among these, 1 significantly inhibited NO production, which is associated with its suppression on iNOS induction in a concentration-dependent manner, with an IC50 of 33.27 ± 0.86 μM. Nevertheless, isometric tension recordings in isolated endothelium-intact rat aorta revealed that 1-4 did not affect acetylcholine-induced endothelial NO-dependent relaxation, an index of endothelial NOS (eNOS) activity. The selective inhibition on iNOS provides a possible explanation for the anti-inflammatory use of M. bracteata.",
keywords = "Bracteanolide A, Bracteanolide B, Commelinaceae, Inducible nitric oxide synthase, Murdannia bracteata, RAW 264.7 cells",
author = "Wang, {Guei Jane} and Chen, {Shih Ming} and Chen, {Wei Chou} and Chang, {Yu Min} and Zong-Huei Li",
year = "2007",
month = "6",
day = "13",
doi = "10.1016/j.jep.2007.02.025",
language = "English",
volume = "112",
pages = "221--227",
journal = "Journal of Ethnopharmacology",
issn = "0378-8741",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Selective inducible nitric oxide synthase suppression by new bracteanolides from Murdannia bracteata

AU - Wang, Guei Jane

AU - Chen, Shih Ming

AU - Chen, Wei Chou

AU - Chang, Yu Min

AU - Li, Zong-Huei

PY - 2007/6/13

Y1 - 2007/6/13

N2 - Murdannia bracteata has been used as a Taiwanese folk medicine for its anti-inflammatory properties. However, neither its active ingredients nor its anti-inflammatory actions are well defined. Nitric oxide (NO), overproduced by activated macrophages via inducible NO synthase (iNOS), is suggested to be a significant pathogenic factor in various inflammatory tissue injuries. In order to elucidate the anti-inflammatory actions of M. bracteata, the present study was designed to isolate its active constituents and examine its effects on iNOS in lipopolysaccharide (LPS)-activated macrophages. Two new hydroxybutenolides, bracteanolide A (1) and B (2), together with (+)-(R)-p-hydroxyphenyllactic acid (3) and isovitexin (4), were isolated and identified from M. bracteata by the NO production assay. All of the compounds inhibited NO production except 3. Their rank order of potency was 1 > 2 > 4. Among these, 1 significantly inhibited NO production, which is associated with its suppression on iNOS induction in a concentration-dependent manner, with an IC50 of 33.27 ± 0.86 μM. Nevertheless, isometric tension recordings in isolated endothelium-intact rat aorta revealed that 1-4 did not affect acetylcholine-induced endothelial NO-dependent relaxation, an index of endothelial NOS (eNOS) activity. The selective inhibition on iNOS provides a possible explanation for the anti-inflammatory use of M. bracteata.

AB - Murdannia bracteata has been used as a Taiwanese folk medicine for its anti-inflammatory properties. However, neither its active ingredients nor its anti-inflammatory actions are well defined. Nitric oxide (NO), overproduced by activated macrophages via inducible NO synthase (iNOS), is suggested to be a significant pathogenic factor in various inflammatory tissue injuries. In order to elucidate the anti-inflammatory actions of M. bracteata, the present study was designed to isolate its active constituents and examine its effects on iNOS in lipopolysaccharide (LPS)-activated macrophages. Two new hydroxybutenolides, bracteanolide A (1) and B (2), together with (+)-(R)-p-hydroxyphenyllactic acid (3) and isovitexin (4), were isolated and identified from M. bracteata by the NO production assay. All of the compounds inhibited NO production except 3. Their rank order of potency was 1 > 2 > 4. Among these, 1 significantly inhibited NO production, which is associated with its suppression on iNOS induction in a concentration-dependent manner, with an IC50 of 33.27 ± 0.86 μM. Nevertheless, isometric tension recordings in isolated endothelium-intact rat aorta revealed that 1-4 did not affect acetylcholine-induced endothelial NO-dependent relaxation, an index of endothelial NOS (eNOS) activity. The selective inhibition on iNOS provides a possible explanation for the anti-inflammatory use of M. bracteata.

KW - Bracteanolide A

KW - Bracteanolide B

KW - Commelinaceae

KW - Inducible nitric oxide synthase

KW - Murdannia bracteata

KW - RAW 264.7 cells

UR - http://www.scopus.com/inward/record.url?scp=34248578992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248578992&partnerID=8YFLogxK

U2 - 10.1016/j.jep.2007.02.025

DO - 10.1016/j.jep.2007.02.025

M3 - Article

C2 - 17442510

AN - SCOPUS:34248578992

VL - 112

SP - 221

EP - 227

JO - Journal of Ethnopharmacology

JF - Journal of Ethnopharmacology

SN - 0378-8741

IS - 2

ER -